Meridian knowledge base

Tesamorelin

Growth-axis & visceral-fat support

Body compositionVisceral fat reductionMetabolic optimizationHealthy aging
SubcutaneousCompounded (503A pharmacy) · not FDA-approved
Mechanism of action

How it works

Tesamorelin is a stabilized analogue of growth hormone-releasing hormone (GHRH). Like sermorelin, it binds pituitary GHRH receptors and stimulates the body's own GH release; a modification to the peptide extends its half-life relative to native GHRH.

Clinical study has focused on effects on visceral adipose tissue — the metabolically active fat surrounding abdominal organs — where growth-axis support has demonstrated reductions in HIV-associated lipodystrophy.

Pharmacology & pharmacokinetics

What is known about the class

Tesamorelin is administered subcutaneously; the pituitary retains normal feedback control, so pulsatile release is preserved.

Providers may monitor IGF-1 and, when relevant, blood glucose during treatment.

Class-level information. Individual dose, schedule, and monitoring are set by the prescribing physician.

Regulatory & compounding status

How this medication is regulated

The FDA has approved brand-name tesamorelin (Egrifta) for a specific indication (HIV-associated lipodystrophy). Meridian tesamorelin is a compounded formulation prepared by a licensed 503A compounding pharmacy under an individual prescription — a distinct product from the FDA-approved brand and not FDA-approved.

The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they are marketed.

Meridian’s approach

If a provider considers Tesamorelin for a member

A synthetic analogue of growth hormone–releasing hormone studied for its effects on body composition — particularly visceral fat — by supporting the body’s own growth-hormone signaling rather than replacing it. At Meridian it is provided as a prescription compounded formulation, prescribed only after an independent physician evaluation.

A provider may evaluate tesamorelin when body composition, visceral-fat reduction, metabolic optimization, or healthy-aging goals are prominent in an individual’s assessment and the clinical picture supports growth-axis support.

A subcutaneous injection, self-administered at home with training and guidance. Dose and schedule are individualized by the prescribing physician — no universal dose is published here.

Considerations & contraindications

What to know

  • This compounded formulation is not an FDA-approved drug; it is prepared by a licensed pharmacy under a physician’s prescription.
  • Not appropriate for everyone — active malignancy and certain pituitary conditions are among the factors your physician reviews carefully.
  • Effects on blood sugar are monitored where relevant; your physician may pair therapy with laboratory follow-up.
  • Results vary and are not guaranteed; therapies are tools within a program, never automatic.
  • A licensed physician independently decides whether tesamorelin is appropriate for you.
Latest research & news

What’s new in Tesamorelin

Curated from public sources. Meridian does not endorse individual studies or news outlets; inclusion is not medical advice.

Nothing new yet — check back soon.

Every treatment option is presented for educational purposes only. All prescribing decisions are made independently by a licensed physician after review of your health history, goals, medications, laboratory information, and clinical evaluation. Nothing on this page is an offer of treatment or a guarantee of outcomes.

Meridian Vitality is a technology and health-services platform. Clinical services are provided by independent licensed medical professionals. Meridian Vitality does not independently diagnose, prescribe, or direct medical care.

Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they are marketed. The availability of a treatment depends on the prescribing provider’s independent medical judgment, pharmacy availability, applicable law, the individual’s medical history, and other clinical considerations.

Potential benefits are not guaranteed. Individual results vary. Meridian Zenith™ is a proprietary Meridian Vitality program name for a compounded oxytocin / bremelanotide formulation.

Find out if Tesamorelin is appropriate for you.

A licensed physician independently reviews your intake and decides — you’re never charged unless care is approved.

Start Your Free Assessment